Introduction
During this module, the DSM-5 will be explored. During this module, you will also be exposed to the Schizophrenia Spectrum and other psychotic disorders that can occur across the lifespan. There are many reasons someone may present with psychosis, and this lesson will help you differentiate which disorder it may accompany.
Learning Outcomes
After completing this module, you will be able to:
Articulate the purpose and use of the DSM-5.
Discuss the etiology and epidemiology of schizophrenia and other psychotic disorders
Describe clinical manifestations of schizophrenia and other psychotic disorders
Identify diagnostic and screening tools that can be used to evaluate patients with schizophrenia and other psychotic disorders
Describe the assessment skills necessary to evaluate a patient with schizophrenia or psychosis
Discuss cultural variances that can impact treatment of a patient with schizophrenia or psychosis
Reading & Resources
Chapters 1, Examination and Diagnosis of the Psychiatric Patient and 5, Schizophrenia Spectrum and Other Psychotic Disorders in Sadock, B., Sadock, V., & Ruiz, P. (2021). Kaplan & Sadock’s synopsis of psychiatry: Behavioral sciences/clinical psychiatry (12th ed.).
Section 1, and review criteria for schizophrenia and psychosis in American Psychiatric Association. (2020). Diagnostic and statistical manual of mental disorders (5th ed.).
Chapter 2, Psychoanalysis in Neukrug, E., & Hays, D. G. (2023). Counseling theory and practice (3rd ed.).
Read aripiprazole, asenapine, chlorpromazine clozapine, haloperidol, lurasidone, olanzapine, paliperidone, quetiapine, risperidone, ziprasidone, and consider how these have been, or may be used, in the treatment of schizophrenia and psychosis in Stahl, S. (2020). Prescriber’s guide: Stahl’s essential psychopharmacology (7th ed.).
PBSNewshour. (2013, May 20). What DSM-5 means for diagnosing mental health patients [Video].
Eleanor Longden. (2013, February). The voices in my head. TED.
American Psychiatric Association. (2020, August). What is schizophrenia?
Zachar, P., Regier, D. A., & Kendler, K. S. (2019). The aspirations for a paradigm shift in DSM-5: An oral history. The Journal of Nervous and Mental Disease, 207(9), 778-784. doi:10.1097/NMD.0000000000001063
Kumari, S., et al. (2018). An assessment of five (PANSS, SAPS, SANS, NGA-16, CGI-SCH) commonly used symptoms rating scales in schizophrenia and comparison to newer scales (CAINS, BNSS). Journal of Addiction and Research Therapy, 8(3), 324.
PANSS (Positive and Negative Symptoms Scale)
Module 2 Lecture Notes
PLACE THIS ORDER OR A SIMILAR ORDER WITH NURSING TERM PAPERS TODAY AND GET AN AMAZING DISCOUNT
